FXR, a multipurpose nuclear receptor.

The farnesoid X receptor (FXR) is a ligand-activated transcription factor and a member of the nuclear receptor superfamily. In the past six years, remarkable inroads have been made into determining the functional importance of FXR. This receptor has been shown to have crucial roles in controlling bile acid homeostasis, lipoprotein and glucose metabolism, hepatic regeneration, intestinal bacterial growth and the response to hepatotoxins. Thus, the development of FXR agonists might prove useful for the treatment of diabetes, cholesterol gallstones, and hepatic and intestinal toxicity.

[1]  T. Willson,et al.  Syndecan-1 Expression Is Regulated in an Isoform-specific Manner by the Farnesoid-X Receptor* , 2003, Journal of Biological Chemistry.

[2]  P. Nestel,et al.  Triglyceride-lowering effect of chenodeoxycholic acid in patients with endogenous hypertriglyceridaemia. , 1974, Lancet.

[3]  A. Morelli,et al.  Cross-Talk between Farnesoid-X-Receptor (FXR) and Peroxisome Proliferator-Activated Receptor γ Contributes to the Antifibrotic Activity of FXR Ligands in Rodent Models of Liver Cirrhosis , 2005, Journal of Pharmacology and Experimental Therapeutics.

[4]  B. Chatterjee,et al.  Dehydroepiandrosterone Sulfotransferase Gene Induction by Bile Acid Activated Farnesoid X Receptor* , 2001, The Journal of Biological Chemistry.

[5]  S. Friedman,et al.  Liver fibrosis -- from bench to bedside. , 2003, Journal of hepatology.

[6]  L. Moore,et al.  A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. , 2000, Molecular cell.

[7]  S. Kliewer,et al.  Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. , 2005, Cell metabolism.

[8]  S. Kliewer,et al.  Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[9]  B. Lewis,et al.  Serum Lipids in Cholelithiasis: Effect of Chenodeoxycholic Acid Therapy , 1973, British medical journal.

[10]  R. Evans,et al.  The Constitutive Androstane Receptor and Pregnane X Receptor Function Coordinately to Prevent Bile Acid-induced Hepatotoxicity* , 2004, Journal of Biological Chemistry.

[11]  Richard J. Thompson,et al.  Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity. , 2004, Gastroenterology.

[12]  R. Sato,et al.  Bile Acid Reduces the Secretion of Very Low Density Lipoprotein by Repressing Microsomal Triglyceride Transfer Protein Gene Expression Mediated by Hepatocyte Nuclear Factor-4* , 2004, Journal of Biological Chemistry.

[13]  D. Mangelsdorf,et al.  LXRS and FXR: the yin and yang of cholesterol and fat metabolism. , 2006, Annual review of physiology.

[14]  T. Willson,et al.  The first completed genome sequence from a teleost fish (Fugu rubripes) adds significant diversity to the nuclear receptor superfamily. , 2003, Nucleic acids research.

[15]  J. Chiang,et al.  Regulation of cholesterol 7α-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRα) , 2001 .

[16]  J. Auwerx,et al.  Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation , 2006, Nature.

[17]  M. Makishima,et al.  Identification of a nuclear receptor for bile acids. , 1999, Science.

[18]  T. A. Kerr,et al.  Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. , 2000, Molecular cell.

[19]  L. Moore,et al.  Identification of a chemical tool for the orphan nuclear receptor FXR. , 2000, Journal of medicinal chemistry.

[20]  M. Karin,et al.  Redundant pathways for negative feedback regulation of bile acid production. , 2002, Developmental cell.

[21]  G. Burckhardt,et al.  Sodium-coupled taurocholate transport in the proximal convolution of the rat kidney in vivo and in vitro. , 1981, The Journal of clinical investigation.

[22]  Bryan Goodwin,et al.  Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. , 2003, The Journal of clinical investigation.

[23]  Paul T Tarr,et al.  Regulation of Multidrug Resistance-associated Protein 2 (ABCC2) by the Nuclear Receptors Pregnane X Receptor, Farnesoid X-activated Receptor, and Constitutive Androstane Receptor* , 2002, The Journal of Biological Chemistry.

[24]  Jasmine Chen,et al.  Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. , 1999, Molecular cell.

[25]  E. Njolito,et al.  Catabolites of cholesterol synthesis pathways and forskolin as activators of the farnesoid X-activated nuclear receptor. , 2000, Toxicology and applied pharmacology.

[26]  B. Staels,et al.  Glucose regulates the expression of the farnesoid X receptor in liver. , 2004, Diabetes.

[27]  Giovanni Galli,et al.  Coordinated Control of Cholesterol Catabolism to Bile Acids and of Gluconeogenesis via a Novel Mechanism of Transcription Regulation Linked to the Fasted-to-fed Cycle* , 2003, Journal of Biological Chemistry.

[28]  D. Russell,et al.  Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis. , 2002, Developmental cell.

[29]  Masataka Harada,et al.  A G Protein-coupled Receptor Responsive to Bile Acids* , 2003, The Journal of Biological Chemistry.

[30]  B. Staels,et al.  FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity. , 2003, Gastroenterology.

[31]  A. Bookout,et al.  Prevention of cholesterol gallstone disease by FXR agonists in a mouse model , 2004, Nature Medicine.

[32]  A. Fukamizu,et al.  Bile Acids Regulate Gluconeogenic Gene Expression via Small Heterodimer Partner-mediated Repression of Hepatocyte Nuclear Factor 4 and Foxo1* , 2004, Journal of Biological Chemistry.

[33]  P. Young,et al.  Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters. , 2002, Gene.

[34]  P. Edwards,et al.  Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) regulates triglyceride metabolism by activation of the nuclear receptor FXR , 2004 .

[35]  C. J. Sinal,et al.  Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice Published, JLR Papers in Press, September 26, 2005. DOI 10.1194/jlr.M500390-JLR200 , 2005, Journal of Lipid Research.

[36]  A. Anisfeld,et al.  BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis. , 2002, Journal of lipid research.

[37]  P. Edwards,et al.  FXR Deficiency Causes Reduced Atherosclerosis in Ldlr−/− Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[38]  D. Moore,et al.  An Orphan Nuclear Hormone Receptor That Lacks a DNA Binding Domain and Heterodimerizes with Other Receptors , 1996, Science.

[39]  T. Willson,et al.  Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids. , 2001, Molecular endocrinology.

[40]  J. Lehmann,et al.  Bile acids: natural ligands for an orphan nuclear receptor. , 1999, Science.

[41]  Masahiro Tohkin,et al.  Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis , 2000, Cell.

[42]  A. Grefhorst,et al.  Transient impairment of the adaptive response to fasting in FXR‐deficient mice , 2005, FEBS letters.

[43]  S. Kliewer,et al.  Complementary Roles of Farnesoid X Receptor, Pregnane X Receptor, and Constitutive Androstane Receptor in Protection against Bile Acid Toxicity* , 2003, Journal of Biological Chemistry.

[44]  Sander M Houten,et al.  Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. , 2004, The Journal of clinical investigation.

[45]  A. Morelli,et al.  The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis. , 2004, Gastroenterology.

[46]  R. Savkur,et al.  Regulation of carbohydrate metabolism by the farnesoid X receptor. , 2005, Endocrinology.

[47]  M. Makishima,et al.  Human Bile Salt Export Pump Promoter Is Transactivated by the Farnesoid X Receptor/Bile Acid Receptor* , 2001, The Journal of Biological Chemistry.

[48]  D. Moore,et al.  Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. , 1995, Molecular endocrinology.

[49]  N. Mitro,et al.  The negative effects of bile acids and tumor necrosis factor-alpha on the transcription of cholesterol 7alpha-hydroxylase gene (CYP7A1) converge to hepatic nuclear factor-4: a novel mechanism of feedback regulation of bile acid synthesis mediated by nuclear receptors. , 2001, The Journal of biological chemistry.

[50]  R. Willén,et al.  The role of bile and bile acids in bacterial translocation in obstructive jaundice in rats. , 1993, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.

[51]  G. Churchill,et al.  FXR and ABCG5/ABCG8 as determinants of cholesterol gallstone formation from quantitative trait locus mapping in mice. , 2003, Gastroenterology.

[52]  Jasmine Chen,et al.  Identification of a nuclear receptor that is activated by farnesol metabolites , 1995, Cell.

[53]  M. Haussler,et al.  Vitamin D Receptor As an Intestinal Bile Acid Sensor , 2002, Science.

[54]  Timothy M Willson,et al.  Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Roger A. Davis,et al.  Regulation of cholesterol-7α-hydroxylase: BAREly missing a SHP , 2002 .

[56]  R. Tangirala,et al.  Farnesoid X Receptor Regulates Bile Acid-Amino Acid Conjugation* , 2003, Journal of Biological Chemistry.

[57]  M. Makishima,et al.  The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. , 2001, Gastroenterology.

[58]  Folkert Kuipers,et al.  The Farnesoid X Receptor Modulates Adiposity and Peripheral Insulin Sensitivity in Mice* , 2006, Journal of Biological Chemistry.

[59]  M. Bowman,et al.  A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR. , 2003, Molecular cell.

[60]  D. Russell The enzymes, regulation, and genetics of bile acid synthesis. , 2003, Annual review of biochemistry.

[61]  Heidi R. Kast-Woelbern,et al.  A role for FXR and human FGF-19 in the repression of paraoxonase-1 gene expression by bile acids Published, JLR Papers in Press, November 3, 2005. , 2006, Journal of Lipid Research.

[62]  S. Kliewer,et al.  Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[63]  P. Dent,et al.  Down-regulation of Cholesterol 7α-Hydroxylase (CYP7A1) Gene Expression by Bile Acids in Primary Rat Hepatocytes Is Mediated by the c-Jun N-terminal Kinase Pathway* , 2001, The Journal of Biological Chemistry.

[64]  R. Blevins,et al.  Farnesoid X Receptor Activates Transcription of the Phospholipid Pump MDR3* , 2003, Journal of Biological Chemistry.

[65]  P. Meier,et al.  Hepatocellular transporters and cholestasis. , 2005, Journal of clinical gastroenterology.

[66]  B. Staels,et al.  The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[67]  J. Auwerx,et al.  The small heterodimer partner interacts with the liver X receptor alpha and represses its transcriptional activity. , 2002, Molecular endocrinology.

[68]  M. Fishbein,et al.  α-Crystallin Is a Target Gene of the Farnesoid X-activated Receptor in Human Livers* , 2005, Journal of Biological Chemistry.

[69]  Jasmine Chen,et al.  Identification of Gene-selective Modulators of the Bile Acid Receptor FXR* , 2003, The Journal of Biological Chemistry.

[70]  Roger A. Davis,et al.  Bile Acids Decrease Hepatic Paraoxonase 1 Expression and Plasma High-Density Lipoprotein Levels Via FXR-Mediated Signaling of FGFR4 , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[71]  D. Mangelsdorf,et al.  A Natural Product That Lowers Cholesterol As an Antagonist Ligand for FXR , 2002, Science.

[72]  P. Dawson,et al.  Regulation of the mouse organic solute transporter α-β, Ostα-Ostβ, by bile acids , 2006 .

[73]  P. Dawson,et al.  The Heteromeric Organic Solute Transporter α-β, Ostα-Ostβ, Is an Ileal Basolateral Bile Acid Transporter* , 2005, Journal of Biological Chemistry.

[74]  D. Mangelsdorf,et al.  Pregnane X Receptor Is a Target of Farnesoid X Receptor* , 2006, Journal of Biological Chemistry.

[75]  D. Moore,et al.  Nuclear Receptor-Dependent Bile Acid Signaling Is Required for Normal Liver Regeneration , 2006, Science.

[76]  Heidi R. Kast-Woelbern,et al.  Natural Structural Variants of the Nuclear Receptor Farnesoid X Receptor Affect Transcriptional Activation* , 2003, The Journal of Biological Chemistry.

[77]  B. Shneider,et al.  Bile acid–induced negative feedback regulation of the human ileal bile acid transporter , 2004 .

[78]  G. Casari,et al.  Identification of Farnesoid X Receptor β as a Novel Mammalian Nuclear Receptor Sensing Lanosterol , 2003, Molecular and Cellular Biology.

[79]  A. Morelli,et al.  A Farnesoid X Receptor-Small Heterodimer Partner Regulatory Cascade Modulates Tissue Metalloproteinase Inhibitor-1 and Matrix Metalloprotease Expression in Hepatic Stellate Cells and Promotes Resolution of Liver Fibrosis , 2005, Journal of Pharmacology and Experimental Therapeutics.

[80]  P. Dawson,et al.  OSTα‐OSTβ: A major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia , 2005 .

[81]  Ke Ma,et al.  Farnesoid X receptor is essential for normal glucose homeostasis. , 2006, The Journal of clinical investigation.

[82]  S. Nelson,et al.  FXR regulates organic solute transporters α and β in the adrenal gland, kidney, and intestine Published, JLR Papers in Press, October 26, 2005. , 2006, Journal of Lipid Research.

[83]  M. Gassull,et al.  Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats , 2003, Hepatology.

[84]  T. Willson,et al.  Identification of a Bile Acid-responsive Element in the Human Ileal Bile Acid-binding Protein Gene , 1999, The Journal of Biological Chemistry.

[85]  G. Shulman,et al.  Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters. , 2006, American journal of physiology. Endocrinology and metabolism.

[86]  Grace Guo,et al.  The Farnesoid X-receptor Is an Essential Regulator of Cholesterol Homeostasis* , 2003, The Journal of Biological Chemistry.

[87]  C. Deng,et al.  Elevated Cholesterol Metabolism and Bile Acid Synthesis in Mice Lacking Membrane Tyrosine Kinase Receptor FGFR4* , 2000, The Journal of Biological Chemistry.